Companies / BOC Sciences / Selicrelumab
BOC Sciences

Selicrelumab | BOC Sciences

Selicrelumab is an agonistic CD40 monoclonal antibody. Selicrelumab binds to CD40 present on the surfaces of some solid tumor cells, leading to apoptosis and decreased tumor growth.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.